De Clercq E - Search Results

1

Database searching for thymidine and thymidylate kinase inhibitors using three-dimensional structure-based methods.

Manallack DT, Pitt WR, Herdewijn P, Balzarini J, De Clercq E, Sanderson MR, Sohi M, Wien F, Munier-Lehmann H, Haouz A, Delarue M. Manallack DT, et al. Among authors: de clercq e. J Enzyme Inhib Med Chem. 2002 Jun;17(3):167-74. doi: 10.1080/14756360290032949. J Enzyme Inhib Med Chem. 2002. PMID: 12443042 Free article.

2

Synthesis and Antiviral Activity of the alpha-Analogues of 1,5-Anhydrohexitol Nucleosides (1,5-Anhydro-2,3-dideoxy-D-ribohexitol Nucleosides).

Hossain N, Rozenski J, De Clercq E, Herdewijn P. Hossain N, et al. Among authors: de clercq e. J Org Chem. 1997 Apr 18;62(8):2442-2447. doi: 10.1021/jo961982m. J Org Chem. 1997. PMID: 11671579

3

A mercapto analogue of 5'-noraristeromycin.

Das SR, Schneller SW, Balzarini J, De Clercq E. Das SR, et al. Among authors: de clercq e. Bioorg Med Chem. 2002 Feb;10(2):457-60. doi: 10.1016/s0968-0896(01)00271-1. Bioorg Med Chem. 2002. PMID: 11741794

4

Anti-angiogenic activity of a novel multi-substrate analogue inhibitor of thymidine phosphorylase.

Liekens S, Bilsen F, De Clercq E, Priego EM, Camarasa MJ, Pérez-Pérez MJ, Balzarini J. Liekens S, et al. Among authors: de clercq e. FEBS Lett. 2002 Jan 2;510(1-2):83-8. doi: 10.1016/s0014-5793(01)03233-1. FEBS Lett. 2002. PMID: 11755536 Free article.

5

Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.

Sienaert R, Naesens L, Brancale A, De Clercq E, McGuigan C, Balzarini J. Sienaert R, et al. Among authors: de clercq e. Mol Pharmacol. 2002 Feb;61(2):249-54. doi: 10.1124/mol.61.2.249. Mol Pharmacol. 2002. PMID: 11809847

6

Influence of 2-substituent on the activity of imidazo[1,2-a] pyridine derivatives against human cytomegalovirus.

Mavel S, Renou JL, Galtier C, Allouchi H, Snoeck R, Andrei G, De Clercq E, Balzarini J, Gueiffier A. Mavel S, et al. Among authors: de clercq e. Bioorg Med Chem. 2002 Apr;10(4):941-6. doi: 10.1016/s0968-0896(01)00347-9. Bioorg Med Chem. 2002. PMID: 11836102

7

6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity.

Holý A, Votruba I, Masojídková M, Andrei G, Snoeck R, Naesens L, De Clercq E, Balzarini J. Holý A, et al. Among authors: de clercq e. J Med Chem. 2002 Apr 25;45(9):1918-29. doi: 10.1021/jm011095y. J Med Chem. 2002. PMID: 11960502

8

Lack of susceptibility of bicyclic nucleoside analogs, highly potent inhibitors of varicella-zoster virus, to the catabolic action of thymidine phosphorylase and dihydropyrimidine dehydrogenase.

Balzarini J, Sienaert R, Liekens S, Van Kuilenburg A, Carangio A, Esnouf R, De Clercq E, McGuigan C. Balzarini J, et al. Among authors: de clercq e. Mol Pharmacol. 2002 May;61(5):1140-5. doi: 10.1124/mol.61.5.1140. Mol Pharmacol. 2002. PMID: 11961132

9

The A167Y mutation converts the herpes simplex virus type 1 thymidine kinase into a guanosine analogue kinase.

Balzarini J, Liekens S, Esnouf R, De Clercq E. Balzarini J, et al. Among authors: de clercq e. Biochemistry. 2002 May 21;41(20):6517-24. doi: 10.1021/bi0255930. Biochemistry. 2002. PMID: 12009916

10

Correlations between cytotoxicity and topography of some 2-arylidenebenzocycloalkanones determined by X-ray crystallography.

Dimmock JR, Zello GA, Oloo EO, Quail JW, Kraatz HB, Perjési P, Aradi F, Takács-Novák K, Allen TM, Santos CL, Balzarini J, De Clercq E, Stables JP. Dimmock JR, et al. Among authors: de clercq e. J Med Chem. 2002 Jul 4;45(14):3103-11. doi: 10.1021/jm010559p. J Med Chem. 2002. PMID: 12086496

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,293 results

Search Page

Filters